Af­ter Chi­nese CD­MO fails, Cam­brex ac­quires in­gre­di­ent man­u­fac­tur­er Snap­drag­on Chem­istry

While CD­MO Cam­brex has been ex­pand­ing steadi­ly through­out the year, its lat­est ac­qui­si­tion sees a deep­er dive in­to the ac­tive phar­ma­ceu­ti­cal in­gre­di­ent game.

The New Jer­sey-based CD­MO has agreed to ac­quire Snap­drag­on Chem­istry, a pro­duc­er of chem­i­cal ser­vices and API man­u­fac­tur­ing for bio­phar­ma cus­tomers. The deal will see Cam­brex ac­quire Snap­drag­on’s two fa­cil­i­ties in Waltham, MA. Cam­brex did not dis­close the deal amount to End­points News.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER